| 证券代码：603733 | 证券简称：仙鹤股份 | 公告编号：2023-058 | | --- | --- | --- | | 债券代码：113632 | 债券简称：鹤21转债 | | 仙鹤股份有限公司 经中国证券监督管理委员会《关于核准仙鹤股份有限公司公开发行可转换公司债券 的批复》（证监许可[2021]3200号）核准，仙鹤股份有限公司（以下简称"公司"、"本 公司"）公开发行可转换公司债券2,050万张，每张面值人民币100元，共计募集资金 205,000.00万元，扣除承销和保荐费用1,086.50万元(含税金额)后的募集资金余额为 203,913.50万元，已由主承销商东方证券承销保荐有限公司（以下简称"东方投行"）于 2021年11月23日汇入本公司募集资金监管账户。本次公开发行可转债发行承销保荐费用及 其他与可转换公司债券直接相关的新增外部费用（不含增值税）共计1,184.58万元，公司 本次公开发行可转换公司债券认购资金总额扣减上述发行费用（不含增值税）后募集资金 净额为人民币203,815.42万元。上述募集资金到位情况业经中汇会计师事务所（特殊普通 合伙）验证，并由其出具中汇会验[20 ...

关于"鹤21转债"预计满足转股价格修正条件 的提示性公告 | 证券代码：603733 | 证券简称：仙鹤股份 | 公告编号：2023-057 | | --- | --- | --- | | 债券代码：113632 | 债券简称：鹤21转债 | | 仙鹤股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、可转债发行上市概况 经中国证券监督管理委员会《关于核准仙鹤股份有限公司公开发行可转换公司债券 的批复》（证监许可[2021]3200号）核准，仙鹤股份有限公司（以下简称"公司"）于 2021年11月17日公开发行了2,050万张可转换公司债券，每张面值为人民币100元，发行 总额为人民币20.50亿元，期限6年。票面利率为第一年0.3%、第二年0.5%、第三年1.0%、 第四年1.5%、第五年1.8%、第六年2.0%。 经上海证券交易所自律监管决定书[2021]461号文同意，公司本次发行的20.50亿元 可转换公司债券于2021年12月9日起在上海证券交易所挂牌交易，债券简称"鹤21转 债"，债券代码"11 ...

| 证券代码：603733 | 证券简称：仙鹤股份 | 公告编号：2023-047 | | --- | --- | --- | | 债券代码：113632 | 债券简称：鹤 21 转债 | | 仙鹤股份有限公司 关于召开 2022 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ● 会议召开时间：2023 年 6 月 9 日（星期五）下午 15:00-16:30 （一）会议召开时间：2023 年 6 月 9 日（星期五）下午 15:00-16:30 （二）会议召开地点：上海证券交易所上证路演中心（http://roadshow.sseinfo.com/） ● 会议召开地点：上海证券交易所上证路演中心（网址：http://roadshow.sseinfo.com/） ● 会议召开方式：上证路演中心视频直播和网络互动 ● 投资者可于 2023 年 6 月 2 日（星期五）至 6 月 8 日（星期四）16：00 前登录上证 路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 zqb@xi ...

证券代码：603733 证券简称：仙鹤股份 公告编号：2023-045 债券代码：113632 债券简称：鹤 21 转债 仙鹤股份有限公司 关于接待机构调研情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 仙鹤股份有限公司（以下简称"公司"）于 2023 年 5 月 18 日通过现场会议 交流形式接待了机构调研，现将情况公告如下： 一、调研情况 调研时间：2023 年 5 月 18 日 调研方式：现场会议交流 调研机构名称（排名不分先后）：国盛证券、源峰基金、招银理财、安信基 金、泰康人寿、招商基金、国华兴益资管、路博迈基金、合远基金、荷宝基 金、东证资管、融通基金、华泰资产、信诚基金 公司接待人员：董事长兼总经理王敏良，副总经理、董事会秘书王昱哲 二、交流的主要问题及公司回复概要 1、请问公司产能投放及规划情况？ 答：公司在建工程按建设规划正稳步推进。夏王纸业 PM5 项目已于 2021 年 12 月下旬顺利投产，释放产能超 7 万吨；常山哲丰 PM9 已于 2021 年 11 月投产， 释放产能 4 万吨， ...

Financial Performance - Q1 2023 revenue reached ¥1,837,474,993.83, an increase of 9.51% year-over-year[5] - Net profit attributable to shareholders was ¥122,128,957.77, a decrease of 16.35% compared to the same period last year[5] - Basic earnings per share for the quarter were ¥0.17, down 19.05% from the previous year[5] - The net profit for Q1 2023 was CNY 122,613,624.21, a decrease of 16.3% compared to CNY 146,434,654.01 in Q1 2022[43] - The total comprehensive income for Q1 2023 was CNY 119,990,043.38, compared to CNY 146,762,601.61 in Q1 2022, indicating a decrease of 18.2%[44] - The net profit for Q1 2023 was ¥59,435,052.86, down 26.5% from ¥80,880,297.93 in Q1 2022[65] Cash Flow - Net cash flow from operating activities was -¥680,330,915.49, representing a decline of 736.43% year-over-year[5] - The company's cash flow from operating activities showed a net outflow of CNY 680,330,915.49, compared to a net inflow of CNY 106,898,217.12 in Q1 2022[56] - The net cash flow from operating activities decreased by RMB 736.43 million, primarily due to an increase in raw material payments[22] - The net cash flow from investing activities decreased by RMB 638.25 million, mainly due to the increase in purchases of new project goods[22] - The net cash flow from financing activities was ¥1,218,823,547.44 in Q1 2023, a significant recovery from a net outflow of ¥59,749,837.43 in Q1 2022[57] - The net cash flow from financing activities was CNY 834,307,588.72, a turnaround from a negative CNY -36,936,695.35 in Q1 2022[70] Assets and Liabilities - Total assets at the end of the reporting period amount to RMB 14,665,994,987.75, reflecting a 10.57% increase from the end of the previous year[18] - Total assets as of March 31, 2023, were ¥14,665,994,987.75, up from ¥13,263,623,257.55 at the end of 2022, reflecting a growth of 10.6%[35] - Total liabilities increased to ¥7,634,188,791.44 in Q1 2023 from ¥6,351,816,196.90 in Q4 2022, an increase of 20.2%[35] - The total liabilities rose to ¥4,857,522,372.42 in Q1 2023, up from ¥3,983,013,739.17 in Q1 2022, indicating an increase of 21.9%[61] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 14,515[11] - The largest shareholder, Zhejiang Xianhe Holding Group Co., Ltd., holds 76.49% of the shares, with 95,000,000 shares pledged[11] - The equity attributable to shareholders of the listed company is RMB 6,999,128,275.63, showing a 1.74% increase compared to the end of the previous year[18] - The total equity attributable to shareholders increased to ¥6,999,128,275.63 in Q1 2023 from ¥6,879,613,806.41 in Q4 2022, showing a growth of 1.7%[35] Operational Metrics - Total operating revenue for Q1 2023 reached ¥1,837,474,993.83, an increase of 9.5% compared to ¥1,677,948,384.45 in Q1 2022[39] - Total operating costs for Q1 2023 were ¥1,740,574,844.84, up from ¥1,558,290,117.89 in Q1 2022, reflecting a year-over-year increase of 11.7%[39] - Research and development expenses in Q1 2023 amounted to ¥23,323,628.25, compared to ¥20,445,852.47 in Q1 2022, indicating a growth of 9.2%[39] - The company's inventory rose to CNY 1,063,985,245.03, up from CNY 781,893,933.32 in the previous year, an increase of 36%[51] Other Financial Metrics - The weighted average return on equity is 1.76%, a decrease of 0.49 percentage points from the previous year[18] - The diluted earnings per share for the reporting period is RMB 0.17, representing a decrease of 26.09% compared to the previous year[18] - The company reported a decrease in tax and additional charges from ¥9,862,975.53 in Q1 2022 to ¥6,721,521.73 in Q1 2023, a reduction of 31.4%[39] - The company reported a decrease in asset impairment losses of RMB 335.34 million, attributed to increased inventory write-down provisions[22] Future Outlook - The company plans to focus on expanding its market presence and investing in new product development to drive future growth[56]

Financial Performance - The company achieved a production volume of 827,500 tons of paper, representing a year-on-year increase of 6.51%[18] - Sales volume reached 811,800 tons, up 15.94% compared to the previous year[18] - The company reported operating revenue of CNY 7,738.31 million, an increase of 28.61% year-on-year[18] - Operating profit decreased by 30.74% to CNY 801.06 million, while total profit fell by 30.84% to CNY 793.91 million[18] - The net profit attributable to ordinary shareholders, after deducting non-recurring gains and losses, was CNY 556.95 million, down 41.87% year-on-year[18] - The company's operating revenue for 2022 was CNY 7,738,308,465.54, an increase of 28.61% compared to CNY 6,016,969,094.64 in 2021[32] - The net profit attributable to shareholders for 2022 was CNY 710,287,829.46, a decrease of 30.14% from CNY 1,016,673,616.75 in 2021[32] - The net cash flow from operating activities decreased by 83.95% to CNY 71,756,508.40 from CNY 447,018,097.64 in the previous year[32] - The operating cost increased to CNY 684,772.87 million, reflecting a year-on-year growth of 42.21%[129] - The continuous rise in raw material costs, particularly wood pulp, led to a decrease in gross margin by 8.46% compared to the previous year[129] - The net profit attributable to shareholders decreased by 30.14% to CNY 710.29 million, primarily due to an 8.46% decline in gross margin and a 51.12% drop in investment income[162] Research and Development - Research and development expenses reached CNY 104.02 million, indicating a commitment to innovation[22] - Research and development expenses decreased by 34.21% to CNY 104,016,805.01 from CNY 158,093,835.21 in the previous year[40] - Total R&D investment amounted to 104,016,805.01 yuan, which is 1.34% of operating revenue[67] - The company invested CNY 104.02 million in R&D expenses during the reporting period, emphasizing the importance of continuous R&D investment for maintaining competitive advantage[178] Market Expansion and Product Development - The company is actively expanding into the food and medical paper markets, responding to increasing demand for eco-friendly packaging materials[21] - The company successfully launched four new products that passed provincial-level new product identification[22] - Sales of food and medical consumer products reached CNY 151,092.08 million, an increase of 52.09% year-on-year[46] - The company is developing a "forest-pulp-paper integration" project and a CNY 10 billion project for high-performance paper-based new materials, both of which are under construction[30] - The company is focusing on building a healthier supply chain management system to enhance the value of strategic partnerships[157] - The company is expanding its market presence in the Southwest region of China, integrating into the Southeast Asian economic circle through the "Pearl River-Xijiang Economic Belt"[112] Environmental and Social Responsibility - The company is actively participating in carbon neutrality initiatives, exploring large-scale afforestation in Guangxi to contribute to carbon reduction[83] - The company invested 71.31 million yuan in environmental protection during the reporting period[200] - The company was listed as a key pollutant discharge unit by the Zhejiang Provincial Department of Ecology and Environment during the reporting period[200] - The company has established a comprehensive ESG management structure, receiving an ESG rating of A, with a AAA rating in the social responsibility category[183] Financial Management and Governance - The company held 11 board meetings during the reporting period, ensuring compliance with governance regulations[119] - The company conducted one annual general meeting and four extraordinary general meetings during the reporting period, with no resolutions being rejected[123] - The company held five shareholder meetings during the reporting period, all compliant with legal regulations[142] - The company maintained effective internal financial reporting controls as of December 31, 2022, according to the internal control audit report by Zhonghui Certified Public Accountants[197] Strategic Goals and Challenges - The company has a strategic goal to become a leading enterprise in the high-performance paper-based functional materials industry, aiming for excellence and international advancement[64] - The company is facing risks from raw material price fluctuations and intensified market competition due to new capacity releases in the specialty paper sector[85] - The company has a strong risk resistance capability, with a diversified product structure across six major series and over 60 varieties, providing more development opportunities and risk dispersion[177] Operational Efficiency - The company expanded its photovoltaic power generation capacity to 34.553 MW, generating 40 million kWh of electricity, equivalent to saving 11,520 tons of standard coal[48] - The company is committed to advancing its "Digital Xianhe" Industry 4.0 management innovation strategy to enhance intelligent manufacturing capabilities[154] - The company implemented a digital transformation strategy, achieving full ERP big data application and establishing a paperless electronic management system[154] - The company has implemented a talent development strategy by combining self-training and the introduction of high-end talent to enhance management capabilities[113] Supply Chain and Procurement - The top five suppliers accounted for a procurement amount of 222,053.02 million yuan, representing 36.78% of the total annual procurement[61] - The net cash flow from operating activities was 71,756,508.40 yuan, a decrease of 83.95% compared to the previous period due to increased raw material procurement costs[69] - The cost of raw materials, primarily imported wood pulp, significantly impacts the company's production costs due to fluctuations in the RMB/USD exchange rate[140] - The company's main business cost increased by 42.38% compared to the same period last year, primarily due to increased market demand and rising raw material prices[173] Dividend Distribution - The company distributed a cash dividend of CNY 3.50 per share, totaling CNY 247.09 million, based on the total number of shares on the dividend record date[191]

Financial Performance - The company's operating revenue for Q3 2022 was ¥1,911,889,882.01, representing a year-on-year increase of 29.54%[6] - The net profit attributable to shareholders for the same period was ¥212,794,950.00, a decrease of 27.70% compared to the previous year[6] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥155,519,575.03, down 42.27% year-on-year[6] - The basic earnings per share for the period was ¥0.30, reflecting a decline of 28.57% compared to the same quarter last year[10] - The diluted earnings per share was ¥0.31, a decrease of 26.19% year-on-year[10] - Total operating revenue for the first three quarters of 2022 reached ¥5,509,896,152.52, an increase of 26.2% compared to ¥4,362,019,783.42 in the same period of 2021[37] - Net profit for the third quarter of 2022 was ¥570,615,015.10, a decrease of 37.0% from ¥905,690,991.03 in the same quarter of 2021[40] - Earnings per share for the third quarter of 2022 were ¥0.80, down from ¥1.28 in the same period last year[46] - Net profit for the first three quarters of 2022 was ¥207,358,847.36, down 63.3% from ¥564,464,302.53 in the same period of 2021[63] Assets and Liabilities - The total assets at the end of the reporting period were ¥13,264,107,664.00, an increase of 20.05% from the end of the previous year[10] - The total assets of the company reached ¥13,264,107,664.00, up from ¥11,048,662,058.09 in the previous year, marking a growth of 20.0%[37] - The total assets as of September 30, 2022, were CNY 9,636,964,777.32, compared to CNY 8,470,536,334.52 at the end of 2021, indicating a growth of 13.8%[54] - The total liabilities increased to ¥6,496,169,340.46 in 2022, compared to ¥4,601,697,466.17 in 2021, reflecting a growth of 41.2%[37] - The company's total current liabilities increased to RMB 4.28 billion from RMB 2.46 billion, reflecting a rise of approximately 74%[35] - The company's total liabilities increased to ¥4,023,364,610.83, up 42.3% from ¥2,827,669,654.23 year-over-year[58] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥530,047,867.95, an increase of 30.46%[10] - The net cash flow from operating activities for the first three quarters of 2022 was CNY 530,047,867.95, an increase of 30.5% compared to CNY 406,297,083.95 in the same period of 2021[47] - The cash inflow from operating activities was 1,196,038,759.59 RMB, down from 1,895,782,253.65 RMB in the same period of 2021, indicating a decrease of approximately 37%[67] - The cash outflow from operating activities was CNY 4,315,200,281.69, compared to CNY 3,605,415,497.05 in the previous year, indicating an increase of 19.6%[47] - The net cash flow from investing activities was CNY -372,900,867.06, worsening from CNY -280,536,724.90 in the same period last year[51] - The net cash flow from investing activities was 154,082,793.04 RMB in the first three quarters of 2022, a recovery from -179,519,070.35 RMB in the previous year[67] Equity and Investments - The equity attributable to shareholders was ¥6,736,628,046.14, up 4.94% from the previous year[10] - The total equity attributable to shareholders reached ¥6,736,628,046.14, an increase of 4.9% from ¥6,419,295,208.03 in the previous year[37] - The company's long-term equity investments rose to RMB 926.95 million, compared to RMB 831.15 million in the previous year, marking an increase of about 11.5%[32] - The company's long-term equity investments rose to CNY 2,096,982,956.48 from CNY 1,527,942,265.75, reflecting a growth of 37.1%[54] Expenses - Total operating costs for the first three quarters of 2022 were ¥5,088,606,603.47, up 40.8% from ¥3,615,756,710.94 in the previous year[37] - Research and development expenses for the first three quarters of 2022 were ¥78,432,822.99, a decrease of 35.8% compared to ¥122,325,738.88 in the same period of 2021[40] - Financial expenses surged to ¥86,057,420.85, compared to ¥4,505,999.02 in the previous year, primarily due to interest expenses of ¥90,019,680.40[60] - The company reported a significant increase in financial expenses, totaling ¥51,378,563.31, compared to ¥19,952,444.60 in the previous year[40] Other Financial Metrics - The company attributed the decline in net profit to rising raw material prices and delayed price increases for products[17] - The company reported non-recurring gains of ¥57,275,374.97 for the quarter[14] - The company reported a decrease in other comprehensive income, with a net amount of -¥2,623,580.83 compared to a gain of ¥327,947.60 in the previous year[63] - The company's cash flow from operating activities showed a significant decline, reflecting challenges in maintaining liquidity[64]

Financial Performance - The company's operating revenue for the first half of 2022 was CNY 3,598,006,270.51, representing a 24.66% increase compared to CNY 2,886,142,610.22 in the same period last year[25]. - The net profit attributable to shareholders of the listed company decreased by 41.83% to CNY 354,179,171.59 from CNY 608,870,186.82 year-on-year[25]. - The net profit after deducting non-recurring gains and losses was CNY 306,945,202.12, down 47.78% from CNY 587,789,193.36 in the previous year[25]. - The net cash flow from operating activities was CNY 430,673,977.66, a decrease of 15.97% compared to CNY 512,515,979.06 in the same period last year[25]. - The total assets at the end of the reporting period were CNY 12,593,931,867.70, an increase of 13.99% from CNY 11,048,662,058.09 at the end of the previous year[25]. - The net assets attributable to shareholders of the listed company increased by 1.61% to CNY 6,522,463,349.81 from CNY 6,419,295,208.03 at the end of the previous year[25]. - Basic earnings per share for the first half of 2022 were CNY 0.50, down 41.86% from CNY 0.86 in the same period last year[25]. - The weighted average return on net assets decreased by 5.39 percentage points to 5.37% from 10.76% in the previous year[25]. Revenue Growth and Market Performance - The company's revenue increased by 24.66% year-over-year, primarily due to stable capacity growth and an increase in market share, with export revenue growing by 119.70% compared to the previous year[26]. - Net profit attributable to shareholders decreased by 41.83% year-over-year, mainly due to a 12% decline in gross margin and a 51% drop in investment income[26]. - Sales of food and medical packaging materials reached CNY 644.46 million, an increase of 31.61% compared to the same period last year, driven by heightened hygiene awareness due to the pandemic[71]. - The sales revenue of electrolytic capacitor paper base materials increased by 19.32% year-on-year during the reporting period, driven by the rapid development of 5G applications[72]. - The sales revenue of label release paper series materials surged by 57.14% year-on-year, reflecting significant growth in the logistics, daily chemicals, food, and pharmaceutical labeling sectors[73]. - The sales revenue of transfer series materials rose by 26.88% year-on-year, benefiting from the growth in the digital transfer market[75]. Production Capacity and Investment - The company has over 1.1 million tons of annual production capacity for specialty paper and paper products, with 51 specialty paper production lines[54]. - The company plans to invest 11.8 billion RMB in the Guangxi Sanjiangkou high-performance paper-based new materials project, aiming for an annual production of 2.5 million tons of specialty pulp and paper[43]. - The company has launched new production capacities, including the PM5-PM8 project with an annual output of 220,000 tons of high-end paper-based functional materials, which has been fully operational[80]. - The company has completed a photovoltaic installation capacity of 10.5 MW, generating an annual electricity output of 11.6 million kWh, equivalent to saving 3,600 tons of standard coal[80]. Research and Development - The company invested CNY 49.66 million in research and development expenses during the reporting period, emphasizing the importance of continuous R&D investment for maintaining competitive advantage[60]. - Research and development investment reached CNY 49.6583 million during the reporting period, with the company applying for 45 patents, including 20 invention patents[78]. - The company holds 48 invention patents and 82 utility model patents, showcasing its commitment to innovation and technology development[58]. Environmental and Social Responsibility - The company has been recognized as a "National Green Factory" and has implemented various environmental management systems to promote sustainable development[61]. - The company has implemented measures to ensure compliance with environmental regulations, achieving zero major pollution incidents during the reporting period[129]. - The wastewater treatment facilities across five production sites are designed to meet the latest national discharge standards, ensuring all treated wastewater is compliant[135]. - The company has established a solid waste management strategy, effectively reducing solid waste emissions and promoting resource recycling[135]. - The company has created over 1,000 job opportunities in 38 poverty alleviation workshops, including 103 positions for impoverished individuals, with total wages exceeding 100 million yuan[149]. - Cumulatively invested over 2 million yuan to support more than 500 impoverished college students since production began[149]. - Distributed over 3 million yuan in relief funds to impoverished households and elderly individuals during festive seasons[149]. Risks and Challenges - The company faces risks from raw material price fluctuations, particularly due to high pulp prices impacting profitability[107]. - The ongoing COVID-19 pandemic poses significant operational risks, with potential impacts on both consumer behavior and external demand for specialty paper products[107]. - The company anticipates increased market competition due to new production capacities in the specialty paper sector[108]. Corporate Governance and Shareholder Commitments - The company commits to not reducing its shares for 36 months post-listing, ensuring stability in share price[165]. - The company will ensure compliance with relevant laws and regulations regarding share reductions and repurchases[168]. - The company will compensate investors for losses resulting from false statements in the IPO prospectus[172]. - The company will publicly disclose reasons for any unfulfilled commitments and apologize to shareholders and the public[183]. - The company will not engage in public refinancing if it fails to fulfill its commitments without force majeure reasons[179].